On Thursday, a sustainable move above Wednesday’s session high of 10,976 could lead the index towards the level of 11,050, followed by 11,100. On the flip side, any dip is likely to find support near the opening upside gap area formed on July 10 (10,860-10,876). Stocks in news: India Glycols, Omaxe, Chambal Fertilisers and Chemicals, Satin Creditcare Network, Coffee Day, Sun Pharmaceutical, MM Forgings, Shree Ajit Pulp and Paper, Shree Cement and HIL. 

A prosperous start is in the store for the Indian markets following optimism seen across the Asian markets in early trading. Nifty 50 index future on the Singapore stock exchange is currently trading with gains of 32 points at 10,979. The key domestic macro events like May IIP and June CPI inflation data are likely to be announced later during the day.

The stocks that are likely to witness significant movement on the bourses on Thursday are Aurobindo Pharma, Power Grid Corporation of India, Idea Cellular Ltd, Reliance Industries Infrastructure and Sun Pharmaceutical Industries.

Post mutual fund categorisation, the portfolio of many mutual fund schemes have changed. This phenomenon has modified the product basket of the mutual fund industry. The best example of this is the change in the equity-oriented hybrid scheme which is now an aggressive hybrid fund.

Equity and balanced funds were very dear to the investors for the last couple of years. These funds have cheered many investors and have seen large inflow in the last year. But for the last few months, these funds have been witnessing a huge decline in their inflows.

Kridhan Infra Limited has announced that its associate company Vijay Nirman Company Private Limited (VNC) has won orders of Rs.74.2 crore.

Following stocks are close to their 52-week low as at 12.57 p.m. on July 11, 2018.

Uflex's film manufacturing arm, Flex Films has successfully developed a Satellite Thermal Radiation Insulation Film as specified by the Indian Space Research Organization (ISRO).

The two companies will collaborate to introduce two new oral anti-diabetics drug in the Indian market. Anti-diabetic drugs Gibtulio Met and Ajaduo were recently approved by the Indian drug regulator.

The markets on July 11, 2018 opened up. BSE Sensex is trading at 36,242.11, up by 2.49 points and the Nifty is trading at 10,943.25, down by 4 points.